TABLE 3.
Markov Model Results for Ribociclib and Palbociclib
| Ribociclib | N or $ |
| All patients | 100 |
| 200 mg tablets wasted for 600 mg dose | 0 |
| 200 mg tablets wasted for 400 mg dose | 0 |
| 200 mg tablets wasted for 200 mg dose | 0 |
| Costs for wastage of 600 mg dose | $0 |
| Costs for wastage of 400 mg dose | $0 |
| Costs for wastage of 200 mg dose | $0 |
| Costs of discontinuation (600 mg dose) | $0 |
| Costs of discontinuation (400 mg dose) | $0 |
| Costs of discontinuation (200 mg dose) | $0 |
| Total cost | $0 |
| Total cost per patient | $0 |
| Palbociclib | N or $ |
| All patients | 100 |
| 125 mg capsule wasted | 184 |
| 100 mg capsule wasted | 25 |
| 75 mg capsule wasted | 0 |
| Costs for wastage of 125 mg dose | $98,939 |
| Costs for wastage of 100 mg dose | $13,443 |
| Costs for wastage of 75 mg dose | $0 |
| Costs of discontinuation (125 mg dose) | $0 |
| Costs of discontinuation (100 mg dose) | $0 |
| Costs of discontinuation (75 mg dose) | $0 |
| Total costs | $112,382 |
| Total cost per patient | $1,124 |